A modified form of low-density lipoprotein with increased electronegative charge is present in rheumatoid arthritis synovial fluid

Free Radical Biology and Medicine

Volumn 22, Issue 4, 1997, Pages 705-710

  Dai, Letian ^a   Zhang, Zhi ^a   Winyard, Paul G ^a   Gaffney, Karl ^a   Jones, Hugh ^a   Blake, David R ^a   Morris, Chris J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Free radicals; LDL; Reactive oxygen species; Rheumatoid arthritis

Indexed keywords

LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ELECTROPHORETIC MOBILITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOELECTROPHORESIS; IMMUNOPATHOGENESIS; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN MODIFICATION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

AGED; ARTHRITIS, RHEUMATOID; ELECTROCHEMISTRY; FEMALE; HUMANS; IMMUNOELECTROPHORESIS, TWO-DIMENSIONAL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OSTEOARTHRITIS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SYNOVIAL FLUID;

EID: 0031019339     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(96)00389-9     Document Type: Article

References (34)

1. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 362:1993;801-809.
2. Kannel W. B., McGee D. L. Diabetes and cardiovascular risk factors: The Framingham study. Circulation. 59:1979;8-13.
3. Svenson K. L. G., Lithell H., Hallgren R., Selinus I., Vessby B. Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity. Arch. Intern. Med. 147:1987;1912-1916.
4. Esterbauer H., Dieber-Rotheneder M., Waeg G., Striegl G., Jurgens G. Biochemical, structural, and functional properties of oxidised low-density lipoprotein. Chem. Res. Toxicol. 3:1990;77-92.
5. More D. W., Hessler J. R., Chisolm G. M. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J. lipid Res. 24:1983;1070-1076.
6. Heinecke J. W., Baker L., Rosen H., Chait A. Superoxide mediated modification of low density lipoprotein by arterial smooth muscle cells. J. Clin. Invest. 77:1986;757-761.
7. Yla-Herttuala S., Palinski W., Rosenfeld M. E., Carew T. E., Butler S., Witztum J. L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1989;1086-1095.
8. Winyard P. G., Tatzber F., Esterbauer H., Kus M. L., Blake D. R., Morris C. J. Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis. Ann. Rheum. Disease. 52:1993;677.
9. Hessler J. R., Robertson A. L., Chisolm G. M. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis. 32:1979;213-229.
10. Qumn M. L., Parthasarathy S., Fong I. G., Steinberg D. Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc. Natl. Acad. Sci. USA. 84:1987;2995-2998.
11. Ku G., Thomas C. E., Akeson A. L., Jackson R. L. Induction of interleukin 1β expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid. J. Biol. Chem. 267:1992;14183-14288.
12. Raymond T. L., Reynolds S. A. Lipoproteins of the extravascular space: Alterations in low density lipoproteins of interstitial inflammatory fluid. J. Lipid Res. 24:1983;113-119.
13. Blake D. R., Merry P., Unsworth J., Kidd B. L., Outhwaite J. M., Ballard R., Morris C. J., Gray L. Hypoxic-reperfusion injury in the inflamed human joint. Lancet. i:1989;289-293.
14. Gutteridge J. M. C., Hill C., Blake D. R. Copper stimulated phospholipid membrane peroxidation: Antioxidant activity of serum and synovial fluid from patients with rheumatoid arthritis. Clin. Chim. Acta. 139:1984;85-90.
15. Lunec J., Blake D. R. The determination of dehydroascorbic acid and ascorbic acid in the serum and synovial fluid of patients with rheumatoid arthritis. Free Radic. Res. Commun. 1:1985;31-39.
16. Fairburn K., Grootveld M., Ward R. J., Abiuka C., Kus M., Williams R. B., Winyard P. G., Blake D. R. α-Tocopherol , lipids and lipoproteins in knee-joint synovial fluid and serum from patients with inflammatory joint disease. Clin. Sci. 83:1993;657-664.
17. Gutteridge J. M. C., Rowley D. A., Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Detection of free iron in biological systems by using bleomycin dependent degradation of DNA. Biochem. J. 199:1981;263-265.
18. Winrow V. R., Winyard P. G., Morris C. J., Blake D. R. Free radicals in inflammation: Second messengers and mediators of tissue destruction. Br. Med. Bull. 49:1993;506-522.
19. Rowley D., Gutteridge J. M. C., Blake D. R., Farr M., Halliwell B. Lipid peroxidation in rheumatoid arthritis: Thiobarbituric acid-reactive material and catalytic iron salt in synovial fluid from rheumatoid patients. Clin. Sci. 66:1984;691-695.
20. Selley M. L., Blourne D. J., Bartlett M. R., Tynns J. E., Brook A. S., Duffield A. M., Ardlie N. G. Occurrence of (E)-4-hydroxy-2-nonenal in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthritis. Ann. Rheum. Dis. 51:1992;481-484.
21. Havel R., Eder H. A., Bragson J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1955;1345-1353.
22. Lowry O. H., Rosenbourg N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
23. Laurell C. B. Antigen-antibody crossed electrophoresis. Anal. Biochem. 10:1965;358-361.
24. Jialal I., Vega G. V., Grundy S. M. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis. 82:1990;185-191.
25. Chen G., Hardman D. A., Hamilton R. L., Mendel C. M., Schilling J. W., Zhu S., Lau K., Wong J. S., Kane J. P. Distribution of lipid-binding regions in human apolipoprotein B-100. Biochemistry. 28:1989;2477-2484.
26. Prete P. E., Gurakar-Osborne A., Kashyap M. L. Synovial fluid lipoproteins: review of current concepts and new directions. Semin Arthritis Rheum. 23:1993;78-89.
27. Small D. M., Cohen A. S., Schmid K. Lipoproteins of synovial fluid as studied by analytical ultracentrifugation. J. Clin. Invest. 43:1964;2070-2079.
28. Morris C. J., Wainwright A. C., Steven M. M., Blake D. R. The nature of iron deposits in haemophilic synovitis: An immunochemical, ultrastructural and X-ray microanalytical study. Virchow. Arch. (Cell Pathol.). 404:1984;75-85.
29. Holvoet P., Peers G., Zhao Z., Brouwers E., Bernar H., Collen D. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. J. Clin. Invest. 95:1995;2611-2619.
30. Raymond T. L., Reynolds S. A., Swanson J. A. Lipoproteins of the extravacular space: Enhanced macrophage degradation of low-density lipoproteins from interstitial inflammatory fluid. J. Lipid Res. 26:1985;1356-1362.
31. Raymond T. L., Reynolds S. A., Swanson J. A. Turnover of low-density lipoprotein isolated from interstitial inflammatory fluid of the rabbit. Inflammation. 10:1986;93-98.
32. Esterbauer H., Jurgens G., Quehenberger O., Loller E. Autoxidation of human low density lipoprotein: Loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J. Lipid Res. 28:1987;495-509.
33. Katsura M., Forster L. A., Ferns G. A. A., Anggard E. E. Oxidative modification of low-density lipoprotein by human polymorphonuclear leucocytes to a form recognised by the lipoprotein scavenger pathway. Biochim. Biophys. Acta. 1213:1994;231-237.
34. Berliner J. A., Territo M. C., Sevanian A., Ramin S., Kim J. A., Ramshad B., Esterson M., Fogelman A. M. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85:1990;1260-1266.